Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200421 | 12720042 | 1 | I | 20160829 | 20160907 | 20160907 | EXP | US-AMGEN-USASL2016115337 | AMGEN | 78.00 | YR | E | M | Y | 85.55000 | KG | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200421 | 12720042 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 40,000 UNITS, ONCE EACH WEEK | U | 103234 | SOLUTION FOR INJECTION | /wk | |||||||
| 127200421 | 12720042 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, ONCE A DAY | 0 | 325 | MG | QD | |||||||
| 127200421 | 12720042 | 3 | C | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, AS NEEDED | 0 | 100 | MG | ||||||||
| 127200421 | 12720042 | 4 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | QD | |||||||
| 127200421 | 12720042 | 5 | C | CENTRUM | VITAMINS | 1 | Oral | UNK UNK, DAILY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127200421 | 12720042 | 1 | Anaemia macrocytic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127200421 | 12720042 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127200421 | 12720042 | Anion gap decreased | |
| 127200421 | 12720042 | Blood glucose increased | |
| 127200421 | 12720042 | Blood iron increased | |
| 127200421 | 12720042 | Blood pressure systolic increased | |
| 127200421 | 12720042 | Blood sodium decreased | |
| 127200421 | 12720042 | Depressed level of consciousness | |
| 127200421 | 12720042 | Disorientation | |
| 127200421 | 12720042 | Haematocrit decreased | |
| 127200421 | 12720042 | Haemoglobin decreased | |
| 127200421 | 12720042 | Increased tendency to bruise | |
| 127200421 | 12720042 | Mean cell haemoglobin increased | |
| 127200421 | 12720042 | Mean cell volume increased | |
| 127200421 | 12720042 | Monocyte count increased | |
| 127200421 | 12720042 | Oropharyngeal pain | |
| 127200421 | 12720042 | Platelet count increased | |
| 127200421 | 12720042 | Red blood cell count decreased | |
| 127200421 | 12720042 | Serum ferritin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127200421 | 12720042 | 1 | 20160622 | 0 |